rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

George Pavlov

Director

Company insider

Files Form 4 as: Director, MapLight Therapeutics; Director and 10% owner, Ikanos Communications; Director, Audience.

In numbers

Trades disclosed
90
Buys
3
Sells
0
Bought
$882K
Sold
$0
Companies
3
Companies where not an officer
3
First trade
24 Aug 2009
Last trade
23 Jun 2026
Last filed
25 Jun 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
MPLT MapLight TherapeuticsDirector · Biotechnology · last 23 Jun 20263 buys · 0 sells
Ikanos CommunicationsDirector, 10% owner · last 28 Sep 20150 buys · 0 sells
AudienceDirector · last 1 Jul 20150 buys · 0 sells

Activity over time

1 Feb – 1 Oct
03Feb 26Apr 26Jun 26Aug 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
23 Jun 2026filed 25 Jun 2026MPLT MapLight TherapeuticsBiotechnologySEC FORM 4 Code A—3,932 at $0.00filing
23 Jun 2026filed 25 Jun 2026MPLT MapLight Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—14,902 at $0.00filing
23 Jun 2026filed 25 Jun 2026MPLT MapLight Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—14,902 at $0.00filing
23 Jun 2026filed 25 Jun 2026MPLT MapLight TherapeuticsBiotechnologySEC FORM 4 Code A—3,932 at $0.00filing
20 Feb 2026filed 20 Feb 2026MPLT MapLight TherapeuticsBiotechnologySEC FORM 4 Bought$177K9,920 at $17.86filing
20 Feb 2026filed 20 Feb 2026MPLT MapLight TherapeuticsBiotechnologySEC FORM 4 Bought$177K9,920 at $17.86filing
19 Feb 2026filed 20 Feb 2026MPLT MapLight TherapeuticsBiotechnologySEC FORM 4 Bought$78K4,422 at $17.57filing
19 Feb 2026filed 20 Feb 2026MPLT MapLight TherapeuticsBiotechnologySEC FORM 4 Bought$78K4,422 at $17.57filing
18 Feb 2026filed 20 Feb 2026MPLT MapLight TherapeuticsBiotechnologySEC FORM 4 Bought$186K10,658 at $17.48filing
18 Feb 2026filed 20 Feb 2026MPLT MapLight TherapeuticsBiotechnologySEC FORM 4 Bought$186K10,658 at $17.48filing
28 Sep 2015filed 29 Sep 2015Ikanos CommunicationsSEC FORM 4 Code U—9,335filing
28 Sep 2015filed 29 Sep 2015Ikanos CommunicationsSEC FORM 4 Code U—8,449,449filing
28 Sep 2015filed 29 Sep 2015Ikanos Communicationsoption or derivativeSEC FORM 4 Code U—5,000filing
1 Jul 2015filed 2 Jul 2015AudienceSEC FORM 4 Code U$12K4,613 at $2.51filing
1 Jul 2015filed 2 Jul 2015AudienceSEC FORM 4 Code U$11.0M4,374,335 at $2.51filing
1 Jul 2015filed 2 Jul 2015Audienceoption or derivativeSEC FORM 4 Code D—14,132filing
1 Jul 2015filed 2 Jul 2015Audienceoption or derivativeSEC FORM 4 Code D—8,079filing
1 Jul 2015filed 2 Jul 2015Audienceoption or derivativeSEC FORM 4 Code D—10,650filing
1 Jul 2015filed 2 Jul 2015Audienceoption or derivativeSEC FORM 4 Code D—15,054filing
6 Jun 2015filed 9 Jun 2015AudienceSEC FORM 4 Code M—2,307 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care3

Buys in green, sells in red, by the company’s sector.

Related people

Christopher A. KroegerChief Executive Officer · Chief Executive Officer at MapLight Therapeutics, filing Form 4 there in the last year
James Woodruff LillieChief Scientific Officer · Chief Scientific Officer at MapLight Therapeutics, filing Form 4 there in the last year
Kristopher HansonGeneral Counsel · General Counsel at MapLight Therapeutics, filing Form 4 there in the last year
Anatol KreitzerChief Discovery Officer · Chief Discovery Officer at MapLight Therapeutics, filing Form 4 there in the last year
Erin Pennock FoffChief Medical Officer · Chief Medical Officer at MapLight Therapeutics, filing Form 4 there in the last year
Jonathan GillisCAO and Interim CFO · Also traded MPLT in the last 90 days
Catalyst4, Inc.10% owner · Also traded MPLT in the last 90 days
Troy CoxDirector · Also traded MPLT in the last 90 days